leukemia

Biogen drug OK'd for leukemia treatment
bizjournals.com
Sat, 02/20/10 - 11:01 am
Biogen Idec
Rituxan
Genentech
leukemia
Novartis' Tasigna gets FDA priority review
Reuters
Fri, 02/19/10 - 09:18 am
Tasigna
FDA
Novartis
leukemia
Roche’s Rituxan Gains U.S. Backing for New Cancer Use
Bloomberg
Thu, 02/18/10 - 08:49 pm
Roche
Rituxan
leukemia
Data Monitoring Committee Recommends Continuation Of Phase III Study Of StemEx(R), A Cord Blood Stem Cell Product, For Leukemia And Lymphoma
Medical News Today
Sat, 02/13/10 - 11:31 am
stem cells
leukemia
lymphoma
StemEx
Genentech, Biogen Idec get FDA request on application for Rituxan's use in leukemia
Yahoo/AP
Thu, 11/19/09 - 07:52 am
Genentech
Roche
Biogen Idec
FDA
Rituxan
leukemia
Genmab Surges After FDA Clears Cancer Drug Shared With Glaxo
Bloomberg
Tue, 10/27/09 - 08:15 am
GSK
Genmab
leukemia
Arzerra
Novartis' Tasigna Seen Succeeding Top Drug Gleevec
WSJ Online
Thu, 10/22/09 - 09:49 am
Novartis
Tasigna
Gleevac
leukemia
Vion Makes Case for Leukemia Drug to FDA Panel
TheStreet.com
Tue, 09/1/09 - 04:00 pm
Vion Pharmaceuticals
FDA
leukemia
Onrigin
FDA: problems with Genzyme study of leukemia drug
Yahoo/AP
Fri, 08/28/09 - 12:15 pm
FDA
Genzyme
leukemia
Clolar
Investors Look Past Cephalon's Leukemia Setback
Yahoo/Zacks.com
Wed, 07/1/09 - 10:07 pm
Cephalon
leukemia
Cephalon says leukemia drug missed goal in trial
Yahoo/AP
Fri, 06/19/09 - 09:19 am
Cephalon
leukemia
lestaurtinib
FDA extends review on Glaxo-Genmab leukemia drug
Marketwatch
Tue, 06/16/09 - 08:33 am
GSK
Genmab
leukemia
Arzerra
Micromet's lead drug meets midstage study goal
Yahoo/AP
Mon, 06/8/09 - 08:45 am
Micromet
blinatumomab
leukemia
ChemGenex Says Leukemia Drug Kills Cancer Stem Cells in Study
Bloomberg
Mon, 06/8/09 - 08:24 am
ChemGenex
leukemia
ChemGenex Says Drug Rids Leukemia in Some Patients
Bloomberg
Tue, 06/2/09 - 07:16 am
ChemGenex
leukemia
Bristol-Myers cancer drug gets full approval
Yahoo/AP
Tue, 05/26/09 - 09:13 pm
Bristol-Myers Squibb
Sprycel
leukemia
The Next Cancer Bestseller?
Forbes
Fri, 04/24/09 - 06:11 am
Novartis
Gleevec
leukemia
kidney cancer
Afinitor
Vion Pharmaceuticals: Onrigin application accepted but barriers remain
Pharmaceutical Business Review
Mon, 04/20/09 - 10:56 am
Vion Pharmaceuticals
Onrigin
FDA
leukemia
FDA Appeal Decision Indicates that Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Trial
StreetInsider.com
Sat, 03/7/09 - 12:47 pm
FDA
drug trials
Genasense
leukemia
Vion files new drug application for leukemia drug
Pharmaceutical Business Review
Thu, 02/19/09 - 06:13 am
Vion Pharmaceuticals
FDA
leukemia
Onrigin
AML
NDA

Pages